Literature DB >> 2548651

Follow-up of two treatment modalities for ductal cancer in situ of the breast.

L G Arnesson1, S Smeds, G Fagerberg, O Gröntoft.   

Abstract

In a mammography screening programme for the early detection of breast cancer 66 cases of ductal cancer in situ of the breast (DCIS) were diagnosed between 1978 and 1984 and prospectively followed up. In the beginning of the study period, DCIS was treated by mastectomy without axillary clearance but sector resection has been performed increasingly. Since 1982 the latter procedure has become standard treatment. Radical resection was confirmed by specimen X-ray and histopathological examination of whole organ sections. No postoperative radiotherapy was given. Twenty-eight women had mastectomy and 38 had sector resection. The median follow-up times were 77 and 60 months respectively. In the mastectomy group postoperative monitoring did not reveal any local recurrence but one contralateral new invasive cancer was discovered. In the sector resection group five recurrences were found. Three of the latter were new cases of DCIS and two appeared as small invasive cancers (stage I). Mastectomy will cure ductal cancer in situ but has a greater morbidity. Sector resection has been established as the method of choice in stage I invasive cancer and is probably also safe in DCIS. The possible beneficial effect of postoperative local radiotherapy after sector resection for DCIS is currently being analysed in a randomized trial which started in Sweden in 1987.

Entities:  

Mesh:

Year:  1989        PMID: 2548651     DOI: 10.1002/bjs.1800760707

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast.

Authors:  Filiz Eren; Zerrin Calay; Haydar Durak; Bülent Eren; Nil Comunoğlu; Ovgü Aydin
Journal:  Bosn J Basic Med Sci       Date:  2012-02       Impact factor: 3.363

Review 2.  Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. A review.

Authors:  A Recht; M J Houlihan
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

Review 3.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

Review 4.  Non-invasive breast carcinoma.

Authors:  M C Posner; N Wolmark
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Management of ductal carcinoma in situ of the breast.

Authors:  J V Reynolds; J P Sweeney; N Nolan; A Korebrits; M J Duffy; E W McDermott; N J O'Higgins
Journal:  Ir J Med Sci       Date:  1993-02       Impact factor: 1.568

Review 6.  The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast.

Authors:  Csaba Polgár; Zsuzsanna Kahán; Zsolt Orosz; Gabriella Gábor; Janaki Hadijev; Gábor Cserni; Janina Kulka; Nóra Jani; Zoltán Sulyok; György Lázár; Gábor Boross; Csaba Diczházi; Eva Szabó; Zsolt László; Zoltán Péntek; Tibor Major; János Fodor
Journal:  Pathol Oncol Res       Date:  2008-04-26       Impact factor: 3.201

Review 7.  Current management of ductal carcinoma in situ.

Authors:  A Barth; R J Brenner; A E Giuliano
Journal:  West J Med       Date:  1995-10

8.  Ductal carcinoma in situ of the breast.

Authors:  Richard J Lee; Laura A Vallow; Sarah A McLaughlin; Katherine S Tzou; Stephanie L Hines; Jennifer L Peterson
Journal:  Int J Surg Oncol       Date:  2012-07-18

9.  Ductal carcinoma in situ of the breast: a surgical perspective.

Authors:  Mohammed Badruddoja
Journal:  Int J Surg Oncol       Date:  2012-09-04

Review 10.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.